Cough Count Validation
Sponsor: KarmelSonix Ltd.
Listed as NCT01413698, this observational or N/A phase trial focuses on Chronic Cough and remains ongoing. Sponsored by KarmelSonix Ltd., it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Apr 2018 — Jan 2021 [monthly]
Unknown Status
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- KarmelSonix Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Jerusalem, Israel